从抗帕金森氏症药物雷沙吉兰到具有乙酰胆碱酯酶和单胺氧化酶抑制和阿尔茨海默病神经保护作用的新型多靶点铁螯合剂

{"title":"从抗帕金森氏症药物雷沙吉兰到具有乙酰胆碱酯酶和单胺氧化酶抑制和阿尔茨海默病神经保护作用的新型多靶点铁螯合剂","authors":"Hailin Zheng, T. Amit, O. Bar-Am, M. Fridkin, S. Mandel, M. Youdim","doi":"10.1007/978-3-319-56015-1_234-1","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19161,"journal":{"name":"NeuroPsychopharmacotherapy","volume":"22 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"From Anti-Parkinson’s Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer’s Disease\",\"authors\":\"Hailin Zheng, T. Amit, O. Bar-Am, M. Fridkin, S. Mandel, M. Youdim\",\"doi\":\"10.1007/978-3-319-56015-1_234-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19161,\"journal\":{\"name\":\"NeuroPsychopharmacotherapy\",\"volume\":\"22 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NeuroPsychopharmacotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/978-3-319-56015-1_234-1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NeuroPsychopharmacotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-3-319-56015-1_234-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}